Clinical features of inflammatory bowel disease unclassified: a case-control study

被引:1
|
作者
Shao, Yupei [1 ]
Zhao, Yixiao [2 ]
Lv, Hong [1 ]
Yan, Pengguang [1 ]
Yang, Hong [1 ]
Li, Jingnan [1 ]
Li, Ji [1 ]
Qian, Jiaming [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gastroenterol, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
[2] Civil Aviat Gen Hosp, Dept Gastroenterol, Beijing 100025, Peoples R China
关键词
Inflammatory bowel disease; Inflammatory bowel disease unclassified; Indeterminate colitis; Clinical features; Prognosis; POUCH-ANAL ANASTOMOSIS; INDETERMINATE COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; RETROSPECTIVE MULTICENTER; DIFFERENTIATION; DIAGNOSIS; GRANULOMA; CONSENSUS; SPECTRUM;
D O I
10.1186/s12876-024-03171-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundApproximately 10-15% of inflammatory bowel disease (IBD) patients with overlapping features of ulcerative colitis (UC) and Crohn's disease (CD) are termed as inflammatory bowel disease unclassified (IBDU). This study aimed to describe the clinical features of IBDU and evaluate the potential associated factors of reclassification.MethodsThe clinical data of 37 IBDU patients were retrospectively analyzed from November 2012 to November 2020. 74 UC and 74 CD patients were randomly selected and age- and sex-matched with the 37 IBDU patients. Clinical characteristics were compared between the three patient groups. Potential factors associated with the IBDU reclassification were evaluated.Results60% of IBDU patients displayed rectal-sparing disease, and 70% of them displayed segmental disease. In comparison to UC and CD, the IBDU group demonstrated higher rates of gastrointestinal bleeding (32.4%), intestinal perforation (13.5%), spontaneous blood on endoscopy (51.4%), and progression (56.8%). The inflammation proceeded relatively slowly, manifesting as chronic alterations like pseudopolyps (78.4%) and haustra blunt or disappearance (56.8%). 60% of IBDU patients exhibited crypt abscess, and 16.7% of them exhibited fissuring ulcers or transmural lymphoid inflammation. The proportions of IBDU patients receiving immunosuppressants, surgery, and infliximab were basically the same as those of CD patients. During the 79 (66, 91) months of follow-up, 24.3% of IBDU patients were reclassified as UC, while 21.6% were reclassified as CD. The presence of intestinal hemorrhaging was associated with CD reclassification, while hypoalbuminemia was associated with UC reclassification.ConclusionsIBDU may evolve into UC or CD during follow-up, and hemorrhage was associated with CD reclassification. Different from the other two groups, IBDU exhibited a more acute onset and a gradual progression. When an IBD patient presents with transmural inflammation or crypt abscess but lacks transmural lymphoid aggregates or fissuring ulcers, the diagnosis of IBDU should be considered.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Clinical features of inflammatory bowel disease unclassified: a case-control study
    Yupei Shao
    Yixiao Zhao
    Hong Lv
    Pengguang Yan
    Hong Yang
    Jingnan Li
    Ji Li
    Jiaming Qian
    [J]. BMC Gastroenterology, 24
  • [2] Clinical Features and Outcome of Patients with Inflammatory Bowel Disease Who Use Narcotics: A Case-Control Study
    Hanson, Karen A.
    Loftus, Edward V., Jr.
    Harmsen, W. Scott
    Diehl, Nancy N.
    Zinsmeister, Alan R.
    Sandborn, William J.
    [J]. INFLAMMATORY BOWEL DISEASES, 2009, 15 (05) : 772 - 777
  • [3] Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: A case-control study
    Hanson, Karen A.
    Loftus, Edward V.
    Harmsen, William S.
    Diehl, Nancy N.
    Zinsmeister, Alan R.
    Sandborn, William J.
    [J]. GASTROENTEROLOGY, 2007, 132 (04) : A654 - A654
  • [4] Inflammatory Bowel Disease Unclassified and Ulcerative Colitis: different outcomes? Multicenter case-control study (Spanish ENEIDA registry)
    Gonzalez Vivo, M.
    Urpi Ferreruela, M.
    Castro Senosiain, B.
    Perez-Martinez, I.
    Barrio, J.
    Codesido Prado, L.
    Caballol Oliva, B.
    Pedrera Roman, V.
    Piqueras Cano, M.
    Rodriguez Moranta, F.
    Casanova Gonzalez, M. J.
    Ramos, L.
    Iborra, M.
    Tardillo Marin, C.
    Barreiro-de Acosta, M.
    Lorente Poyatos, R. H.
    Orts Jorquera, B.
    Bujanda Fernandez, L.
    Zabana, Y.
    Lopez-Garcia, A.
    Riestra, S.
    Vega-Villaamil, P.
    Montoro, M.
    Gisbert, J. P.
    Nos, P.
    Rodriguez Gonzalez, G. E.
    Porto Silva, M.
    Gutierrez-Casbas, A.
    Domenech, E.
    Marquez, L.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I208 - I209
  • [5] Case-control study of the concurrence of coeliac disease with inflammatory bowel disease
    Sonnenberg, Amnon
    Genta, Robert. M. M.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (09) : 988 - 992
  • [6] ALEXITHYMIA IN INFLAMMATORY BOWEL-DISEASE - A CASE-CONTROL STUDY
    PORCELLI, P
    ZAKA, S
    LEOCI, C
    CENTONZE, S
    TAYLOR, GJ
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 1995, 64 (01) : 49 - 53
  • [7] Periodontitis and Gingivitis in Inflammatory Bowel Disease: A Case-Control Study
    Vavricka, Stephan R.
    Manser, Christine N.
    Hediger, Sebastian
    Voegelin, Marius
    Scharl, Michael
    Biedermann, Luc
    Rogler, Sebastian
    Seibold, Frank
    Sanderink, Rene
    Attin, Thomas
    Schoepfer, Alain
    Fried, Michael
    Rogler, Gerhard
    Frei, Pascal
    [J]. INFLAMMATORY BOWEL DISEASES, 2013, 19 (13) : 2768 - 2777
  • [8] A case-control study on risk factors in Inflammatory bowel disease
    Zhu Zhenhua
    Zeng Zhirong
    Peng Xiabiao
    Peng Lin
    Hao Yuantao
    Qian Jiaming
    Chien, Ng Siew
    Chen Minhu
    Hu Pinjin
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 145 - 145
  • [9] HIDRADENITIS SUPPURATIVA AND INFLAMMATORY BOWEL DISEASE IN A CASE-CONTROL STUDY
    Neri, B.
    Mossa, M.
    Pensa, C.
    Lambiase, S.
    Cannizzaro, M., V
    Mancone, R.
    Calabrese, E.
    Campione, E.
    Monteleone, G.
    Biancone, L.
    [J]. DIGESTIVE AND LIVER DISEASE, 2022, 54 : S137 - S137
  • [10] A case-control study of measles vaccination and inflammatory bowel disease
    Feeney, M
    Clegg, A
    Winwood, P
    Snook, J
    [J]. LANCET, 1997, 350 (9080): : 764 - 766